Skip to main content

Table 4 Prognostic factors in the univariate analyses for overall survival

From: Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer

Variables

Median OS (months)

p

Age

  

   60 years and over

11 ± 2

0.87

   Less than 60 years

12 ± 3

 

Gender

  

   Male

9 ± 3

0.22

   Female

15 ± 6

 

PS

  

   0

15 ± 3

0.015*

   1–2

6 ± 2

 

Histology

  

   Adenocarcinoma

15 ± 5

0.73

   Squamous cell

13 ± 7

 

   NSCLC

11 ± 3

 

Stage at presentation

  

   III

NR†

0.018*

   IV

9 ± 2

 

Smoking history

  

   Yes

9 ± 2

0.20

   No

NR†

 

Response after 3 cycles of CT

  

   PR

13 ± 2

0.047*

   Other

6 ± 1

 
  1. * Statistically significant
  2. † Mean OS is 15 ± 2 months
  3. PS: ECOG Performance status; NR: Not reached; CT: Chemotherapy
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us